urapidil has been researched along with Diabetes Mellitus in 1 studies
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pharmacological treatment options for underactive bladder (UAB) syndrome are limited." | 1.72 | Therapeutic effects of silodosin and urapidil on underactive bladder associated with diabetic cystopathy. ( Takeda, H; Tatemichi, S; Tezuka, M; Yonekubo-Awaka, S, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yonekubo-Awaka, S | 1 |
| Tezuka, M | 1 |
| Tatemichi, S | 1 |
| Takeda, H | 1 |
1 other study available for urapidil and Diabetes Mellitus
| Article | Year |
|---|---|
Therapeutic effects of silodosin and urapidil on underactive bladder associated with diabetic cystopathy.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Diabetes Mellitus; Female; Midodrine; Rats; Strept | 2022 |